6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinzirskaya, YA; Siprov, AV | 1 |
1 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Neoplasms
| Article | Year |
|---|---|
The use of emoxipin for correction of cyclophosphamide cytotoxicity in experimental animals.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Bone Marrow Cells; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Picolines | 2008 |